Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
3 trials match this view; 3 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 38 across 3 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Countries with reported trial locations
Sponsors recorded in this index
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted TherapyBorderline Personality Disorder · Borderline Personality Pathology · Depressive Symptoms · Emotion Dysregulation · Suicidal Ideation | University of Minnesota PHASE1 | Not yet recruiting Registry updated 2026-09-22 | 18 ESTIMATED | 2026-12-01 2029-12-31 2030-12-31 | |
| Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesSuicidal Ideation | University of New Mexico PHASE2 | Withdrawn Registry updated 2026-03-20 | 0 ACTUAL | 2026-05-01 2029-08-31 2029-08-31 | |
| The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationTreatment Resistant Depression · Suicidal Ideation | Sheppard Pratt Health System PHASE2 | Completed Registry updated 2025-12-24 | 20 ACTUAL | 2022-03-28 2025-05-12 2025-05-12 |
Reported research facilities
M Health Fairview DBT ProgramMinneapolis, Minnesota, United States
M Physicians St. Louis Park ClinicSaint Louis Park, Minnesota, United States
Sheppard Pratt Health SystemBaltimore, Maryland, United States
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.